Dr. Barry W. Goy explains how to interpret PSA levels after prostate cancer treatment and how to manage recurrence based on ...

Prostate cancer is often seen as an unavoidable part of ageing, especially among men, but there are many myths that can ...

A new study by UC San Francisco found that prostate cancer cases are increasing in California, likely due to a change in ...

A mobile prostate cancer screening program proved feasible for men in underserved neighborhoods and led to a high rate of ...

Testosterone therapy after prostate cancer surgery does not appear to increase biochemical recurrence (BCR) risk in patients with low-risk disease, investigators report.

Although carbon ion radiation led to a decline in urinary function among patients with prostate cancer, function returned to ...

A nurse-led mobile healthcare clinic identified a high proportion of clinically significant prostate cancers among men from ...

New research maps the global burden of male cancers from 1990 to 2040, showing how aging, lifestyle, and healthcare access ...

The current gold-standard test for prostate cancer is the prostate-specific antigen (PSA ... Researchers plan to study the ...

New Data at ASCO GU Show Power of Veracyte’s Decipher Tests to Improve Patient Care and Its GRID Tool to Advance Prostate and ...

Cases of prostate cancer are on the rise in California ... is now available and is poised to spare men with low risk disease from unnecessary treatment while ensuring early detection for men ...